Trial intelligence / Profile preview

Bioequivalence study of Finasteride 1 mg tablets vs Propecia 1 mg tablets in healthy Thai male volunteers under fasting conditions

TCTR20220408004Phase 1Not yet recruiting

Sponsor
Bio-innova
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of finasteride in androgenetic alopecia (AGA) (2 arms), sponsored by Bio-innova. Planned start Jul 2022; status: not yet recruiting.

02

Drugs

finasteride
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on TCTR20220408004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220408004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call